US Stock MarketDetailed Quotes

RANI Rani Therapeutics

Watchlist

3.180
+1.160+57.43%

Close Oct 14 16:00 ET

3.540
+0.360+11.32%

Post 20:02 ET

93.14MMarket Cap-2694P/E (TTM)

Rani Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

26.60%-9.03M

22.64%-9.4M

-10.15%-51.24M

14.70%-12.48M

-17.26%-14.3M

-19.10%-12.3M

-29.85%-12.15M

-44.25%-46.52M

-27.78%-14.63M

-9.69%-12.2M

Net income from continuing operations

28.41%-13.36M

12.20%-14.78M

-7.17%-67.88M

18.95%-14.06M

-13.10%-18.33M

-16.90%-18.66M

-21.72%-16.83M

-19.32%-63.34M

-30.34%-17.34M

43.53%-16.21M

Depreciation and amortization

34.92%255K

31.91%248K

50.00%822K

30.46%227K

54.61%218K

54.92%189K

69.37%188K

10.26%548K

53.98%174K

17.50%141K

Other non cash items

-50.63%157K

37.11%436K

51.37%1.27M

8.50%319K

38.26%318K

98.75%318K

102.55%318K

671.56%841K

29,300.00%294K

1,537.50%230K

Change In working capital

-93.56%81K

155.04%1.16M

-520.43%-2.14M

-85.37%-2.99M

-56.24%-864K

-8.84%1.26M

-64.79%456K

114.84%509K

-13.43%-1.61M

72.42%-553K

-Change in prepaid assets

24.26%676K

57.91%499K

-44.16%282K

-44.05%348K

36.01%-926K

-10.67%544K

-56.17%316K

125.57%505K

29.58%622K

41.11%-1.45M

-Change in payables and accrued expense

-150.82%-496K

161.15%1.04M

-247.79%-1.14M

-41.62%-2.83M

-70.95%321K

4.83%976K

-45.42%399K

-39.19%768K

-5.10%-2M

144.47%1.11M

-Change in other current assets

----

---245K

----

--0

----

-Change in other current liabilities

62.21%-99K

-45.95%-378K

-36.39%-1.04M

-11.02%-262K

-22.75%-259K

-63.75%-262K

-64.97%-259K

---764K

---236K

---211K

Cash from discontinued investing activities

Operating cash flow

26.60%-9.03M

22.64%-9.4M

-10.15%-51.24M

14.70%-12.48M

-17.26%-14.3M

-19.10%-12.3M

-29.85%-12.15M

-44.25%-46.52M

-27.78%-14.63M

-9.69%-12.2M

Investing cash flow

Cash flow from continuing investing activities

727.00%6.53M

149.67%10.29M

141.22%29.86M

3,004.60%13.27M

116.36%11.67M

308.18%789K

1,723.23%4.12M

-14,215.42%-72.44M

-68.63%-457K

-71.35M

Net PPE purchase and sale

71.94%-94K

92.74%-18K

24.09%-1.23M

68.49%-167K

-5.04%-479K

11.61%-335K

2.36%-248K

-219.96%-1.62M

-95.57%-530K

---456K

Net investment purchase and sale

488.88%6.62M

135.92%10.31M

143.90%31.09M

18,312.33%13.44M

117.14%12.15M

--1.12M

--4.37M

---70.82M

--73K

---70.89M

Cash from discontinued investing activities

Investing cash flow

727.00%6.53M

149.67%10.29M

141.22%29.86M

3,004.60%13.27M

116.36%11.67M

308.18%789K

1,723.23%4.12M

-14,215.42%-72.44M

-68.63%-457K

---71.35M

Financing cash flow

Cash flow from continuing financing activities

76.25%141K

1,412.50%121K

-99.20%233K

-99.35%96K

-99.65%49K

63.27%80K

-62.40%29.01M

2,709.47%14.87M

-80.32%14.08M

Net issuance payments of debt

----

--0

----

1,138.41%29.57M

--14.9M

----

Proceeds from stock option exercised by employees

85.39%165K

-8.33%121K

24.61%395K

-21.95%96K

-46.21%78K

81.63%89K

--132K

1,119.23%317K

--123K

1,015.38%145K

Net other financing activities

----

81.72%-162K

--0

---29K

---9K

---124K

---886K

---152K

----

Cash from discontinued financing activities

Financing cash flow

76.25%141K

1,412.50%121K

-99.20%233K

-99.35%96K

-99.65%49K

63.27%80K

--8K

-62.40%29.01M

2,709.47%14.87M

-80.32%14.08M

Net cash flow

Beginning cash position

-62.14%7.38M

-76.86%6.36M

-76.58%27.51M

-80.26%5.47M

-91.71%8.05M

-81.93%19.48M

-76.58%27.51M

60.77%117.45M

-78.64%27.72M

40.20%97.18M

Current changes in cash

79.33%-2.36M

112.63%1.01M

76.49%-21.14M

520.75%892K

96.29%-2.58M

-7.26%-11.43M

16.55%-8.02M

-302.60%-89.95M

98.28%-212K

-214.95%-69.46M

End cash Position

-37.73%5.01M

-62.14%7.38M

-76.86%6.36M

-80.26%5.47M

-91.71%8.05M

-81.93%19.48M

-76.58%27.51M

-78.64%27.72M

Free cash flow

27.80%-9.12M

24.04%-9.42M

-9.00%-52.47M

16.58%-12.65M

-16.82%-14.78M

-18.02%-12.64M

-29.00%-12.4M

-46.97%-48.13M

-29.34%-15.16M

-13.79%-12.65M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	26.60%-9.03M	22.64%-9.4M	-10.15%-51.24M	14.70%-12.48M	-17.26%-14.3M	-19.10%-12.3M	-29.85%-12.15M	-44.25%-46.52M	-27.78%-14.63M	-9.69%-12.2M
Net income from continuing operations	28.41%-13.36M	12.20%-14.78M	-7.17%-67.88M	18.95%-14.06M	-13.10%-18.33M	-16.90%-18.66M	-21.72%-16.83M	-19.32%-63.34M	-30.34%-17.34M	43.53%-16.21M
Depreciation and amortization	34.92%255K	31.91%248K	50.00%822K	30.46%227K	54.61%218K	54.92%189K	69.37%188K	10.26%548K	53.98%174K	17.50%141K
Other non cash items	-50.63%157K	37.11%436K	51.37%1.27M	8.50%319K	38.26%318K	98.75%318K	102.55%318K	671.56%841K	29,300.00%294K	1,537.50%230K
Change In working capital	-93.56%81K	155.04%1.16M	-520.43%-2.14M	-85.37%-2.99M	-56.24%-864K	-8.84%1.26M	-64.79%456K	114.84%509K	-13.43%-1.61M	72.42%-553K
-Change in prepaid assets	24.26%676K	57.91%499K	-44.16%282K	-44.05%348K	36.01%-926K	-10.67%544K	-56.17%316K	125.57%505K	29.58%622K	41.11%-1.45M
-Change in payables and accrued expense	-150.82%-496K	161.15%1.04M	-247.79%-1.14M	-41.62%-2.83M	-70.95%321K	4.83%976K	-45.42%399K	-39.19%768K	-5.10%-2M	144.47%1.11M
-Change in other current assets	----	----	---245K	----	----	----	----	--0	----	----
-Change in other current liabilities	62.21%-99K	-45.95%-378K	-36.39%-1.04M	-11.02%-262K	-22.75%-259K	-63.75%-262K	-64.97%-259K	---764K	---236K	---211K
Cash from discontinued investing activities
Operating cash flow	26.60%-9.03M	22.64%-9.4M	-10.15%-51.24M	14.70%-12.48M	-17.26%-14.3M	-19.10%-12.3M	-29.85%-12.15M	-44.25%-46.52M	-27.78%-14.63M	-9.69%-12.2M
Investing cash flow
Cash flow from continuing investing activities	727.00%6.53M	149.67%10.29M	141.22%29.86M	3,004.60%13.27M	116.36%11.67M	308.18%789K	1,723.23%4.12M	-14,215.42%-72.44M	-68.63%-457K	-71.35M
Net PPE purchase and sale	71.94%-94K	92.74%-18K	24.09%-1.23M	68.49%-167K	-5.04%-479K	11.61%-335K	2.36%-248K	-219.96%-1.62M	-95.57%-530K	---456K
Net investment purchase and sale	488.88%6.62M	135.92%10.31M	143.90%31.09M	18,312.33%13.44M	117.14%12.15M	--1.12M	--4.37M	---70.82M	--73K	---70.89M
Cash from discontinued investing activities
Investing cash flow	727.00%6.53M	149.67%10.29M	141.22%29.86M	3,004.60%13.27M	116.36%11.67M	308.18%789K	1,723.23%4.12M	-14,215.42%-72.44M	-68.63%-457K	---71.35M
Financing cash flow
Cash flow from continuing financing activities	76.25%141K	1,412.50%121K	-99.20%233K	-99.35%96K	-99.65%49K	63.27%80K	8K	-62.40%29.01M	2,709.47%14.87M	-80.32%14.08M
Net issuance payments of debt	----	----	--0	--0	----	----	----	1,138.41%29.57M	--14.9M	----
Proceeds from stock option exercised by employees	85.39%165K	-8.33%121K	24.61%395K	-21.95%96K	-46.21%78K	81.63%89K	--132K	1,119.23%317K	--123K	1,015.38%145K
Net other financing activities	----	----	81.72%-162K	--0	---29K	---9K	---124K	---886K	---152K	----
Cash from discontinued financing activities
Financing cash flow	76.25%141K	1,412.50%121K	-99.20%233K	-99.35%96K	-99.65%49K	63.27%80K	--8K	-62.40%29.01M	2,709.47%14.87M	-80.32%14.08M
Net cash flow
Beginning cash position	-62.14%7.38M	-76.86%6.36M	-76.58%27.51M	-80.26%5.47M	-91.71%8.05M	-81.93%19.48M	-76.58%27.51M	60.77%117.45M	-78.64%27.72M	40.20%97.18M
Current changes in cash	79.33%-2.36M	112.63%1.01M	76.49%-21.14M	520.75%892K	96.29%-2.58M	-7.26%-11.43M	16.55%-8.02M	-302.60%-89.95M	98.28%-212K	-214.95%-69.46M
End cash Position	-37.73%5.01M	-62.14%7.38M	-76.86%6.36M	-76.86%6.36M	-80.26%5.47M	-91.71%8.05M	-81.93%19.48M	-76.58%27.51M	-76.58%27.51M	-78.64%27.72M
Free cash flow	27.80%-9.12M	24.04%-9.42M	-9.00%-52.47M	16.58%-12.65M	-16.82%-14.78M	-18.02%-12.64M	-29.00%-12.4M	-46.97%-48.13M	-29.34%-15.16M	-13.79%-12.65M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data